Christopher S. Wisniewski, Pharm.D., BCPS, is Assistant Professor of Clinical Pharmacy and Outcome Sciences, South Carolina College of Pharmacy, Medical University of South Carolina (MUSC) Campus, Charleston, and Clinical Pharmacy Specialist, Medication Use Policy and Informatics, MUSC. Sophie Robert, B.Pharm., Pharm.D., BCPP, is Clinical Pharmacy Consultant, SCORxE Academic Detailing Service, and Adjunct Assistant Professor, South Carolina College of Pharmacy, MUSC. Sarah Ball, Pharm.D., is Director, SCORxE Academic Detailing Service, and Assistant Professor, Department of Clinical Pharmacy and Outcome Sciences, South Carolina College of Pharmacy, University of South Carolina Campus, Columbia.
Am J Health Syst Pharm. 2014 Jan 15;71(2):128-33. doi: 10.2146/ajhp130225.
The collaboration between a drug information center (DIC) and an academic detailing program is described.
An agreement was reached between the South Carolina Offering Prescribing Excellence (SCORxE) academic detailing program and the Medical University of South Carolina (MUSC) Drug Information Center (DIC) to provide responses to drug information (DI) questions pharmacists received on academic detailing visits. Questions received were analyzed to determine the impact that the collaboration had on MUSC DIC requests.
From May 2009 to October 2012, the MUSC DIC answered 2727 DI questions, 62 (2.3%) of which were generated by SCORxE. Compared with DIC questions received from other sources, academic detailing questions were more likely to be therapeutic consultations, reference searches, or dosage queries and less likely to be about formulation or drug interactions. When comparing the deadline for the 62 academic detailing requests with the deadline for all other requests, the academic detailing requests allowed for a longer median time to deadline per request (21.2 days versus 27.1 hours). The majority of SCORxE questions (68%) were completed by students or residents. Benefits of the collaboration for the DIC included advanced educational opportunities for learners, increased dissemination of provided information, external funding, and scholarship opportunities. SCORxE has benefited from increased access to information and efficiency.
Collaboration between an academic detailing program and an academic medical center DIC has proven beneficial for both parties. Questions have been communicated by a simple and effective process and have required more research than queries received from other sources.
描述了一个药物信息中心(DIC)与学术细化项目之间的合作。
南卡罗来纳州提供卓越处方(SCORxE)学术细化项目与南卡罗来纳医科大学(MUSC)药物信息中心(DIC)达成协议,为药剂师在学术细化访问中收到的药物信息(DI)问题提供答复。对收到的问题进行了分析,以确定合作对 MUSC DIC 请求的影响。
从 2009 年 5 月至 2012 年 10 月,MUSC DIC 回答了 2727 个 DI 问题,其中 62 个(2.3%)是由 SCORxE 产生的。与来自其他来源的 DIC 问题相比,学术细化问题更可能是治疗咨询、参考搜索或剂量查询,而不太可能是关于配方或药物相互作用的问题。在比较 62 个学术细化请求的截止日期与所有其他请求的截止日期时,学术细化请求允许每个请求的中位数截止日期更长(21.2 天与 27.1 小时)。大多数 SCORxE 问题(68%)由学生或住院医师完成。该合作对 DIC 的好处包括学习者的高级教育机会、提供信息的更多传播、外部资金和奖学金机会。SCORxE 从增加信息获取和提高效率中受益。
学术细化项目与学术医疗中心 DIC 之间的合作对双方都有好处。通过简单有效的流程进行了沟通,并且比从其他来源收到的查询需要更多的研究。